Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,324
Closed -$694K 3677
2025
Q4
$694K Sell
9,324
-28,756
-76% -$2.1M ﹤0.01% 2220
2025
Q3
$2.57M Sell
38,080
-31,964
-46% -$2.12M ﹤0.01% 1278
2025
Q2
$4.56M Buy
70,044
+21,444
+44% +$1.29M 0.01% 906
2025
Q1
$3M Buy
48,600
+15,116
+45% +$1M 0.01% 1025
2024
Q4
$2.41M Sell
33,484
-5,719
-15% -$447K ﹤0.01% 1114
2024
Q3
$3.19M Buy
39,203
+3,391
+9% +$271K 0.01% 963
2024
Q2
$2.66M Buy
35,812
+1,078
+3% +$80.8K 0.01% 967
2024
Q1
$2.71M Buy
34,734
+11,375
+49% +$846K 0.01% 962
2023
Q4
$1.67M Buy
23,359
+5,957
+34% +$415K ﹤0.01% 1146
2023
Q3
$1.21M Sell
17,402
-35
-0.2% -$2.65K ﹤0.01% 1221
2023
Q2
$1.41M Buy
17,437
+1,726
+11% +$141K ﹤0.01% 1121
2023
Q1
$1.27M Buy
15,711
+1,178
+8% +$94.8K ﹤0.01% 1162
2022
Q4
$1.09M Buy
14,533
+1,792
+14% +$128K ﹤0.01% 1197
2022
Q3
$822K Buy
12,741
+85
+0.7% +$5.89K ﹤0.01% 1140
2022
Q2
$877K Buy
12,656
+540
+4% +$40.1K ﹤0.01% 947
2022
Q1
$931K Buy
+12,116
New +$871K ﹤0.01% 956

Other funds holding HOLX

Mariner's HOLX Position: Q1 2026 in Review

Mariner sold out of Hologic (HOLX) in Q1 2026, closing a stake of 9,324 shares — an estimated $694K sold.

Mariner first reported a position in HOLX in Q1 2022 and held it in 16 quarters. The position peaked at $4.56M in Q2 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Mariner reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Mariner sold 9,324 Hologic shares in Q1 2026, an estimated $694K.
  • Mariner first reported a position in Hologic in Q1 2022 and held it in 16 quarters.
  • Mariner's Hologic position peaked at $4.56M in Q2 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.